You are here

  • Home
  • Archive
  • Volume 26, Issue 1
  • Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis

Article info

Article menu

Download PDFPDF

Pharmacological treatments
Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis

Authors

  • Luis Souza Motta Section of Negative Affect and Social Processes, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Natan Pereira Gosmann Section of Negative Affect and Social Processes, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Postgraduate Program in Psychiatry and Behavioral Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Anxiety Disorders Outpatient Program, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Marianna de Abreu Costa Anxiety Disorders Outpatient Program, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Marianna de Barros Jaeger Anxiety Disorders Outpatient Program, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Júlia Frozi Section of Negative Affect and Social Processes, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Laura Tietzmann Grevet School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Lucas Spanemberg School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Gisele Gus Manfro Postgraduate Program in Psychiatry and Behavioral Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Anxiety Disorders Outpatient Program, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil PubMed articlesGoogle scholar articles
  • Pim Cuijpers Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Daniel Samuel Pine Emotion and Development Branch, Section on Development and Affective Neuroscience, National Institute of Mental Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Giovanni Salum Section of Negative Affect and Social Processes, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Postgraduate Program in Psychiatry and Behavioral Sciences, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), São Paulo, Brazil Child Mind Institute, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Natan Pereira Gosmann, Section of Negative Affect and Social Processes, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-003, Brazil; natanpgosmann{at}gmail.com
View Full Text

Citation

Motta LS, Gosmann NP, Costa MDA, et al
Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis
BMJ Ment Health 2023;26:e300630.

Publication history

  • Received November 16, 2022
  • Accepted April 7, 2023
  • First published May 4, 2023.
Online issue publication 
May 04, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.